HM Payson & Co. grew its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 404.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 181,377 shares of the pharmacy operator’s stock after acquiring an additional 145,422 shares during the period. HM Payson & Co.’s holdings in Walgreens Boots Alliance were worth $13,222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of WBA. Sei Investments Co. boosted its holdings in Walgreens Boots Alliance by 100.9% in the 2nd quarter. Sei Investments Co. now owns 349,451 shares of the pharmacy operator’s stock worth $20,970,000 after buying an additional 175,551 shares during the period. California Public Employees Retirement System lifted its stake in Walgreens Boots Alliance by 7.7% in the 2nd quarter. California Public Employees Retirement System now owns 2,303,917 shares of the pharmacy operator’s stock worth $138,270,000 after purchasing an additional 165,048 shares in the last quarter. We Are One Seven LLC purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth $1,295,000. Bridgewater Associates LP lifted its stake in Walgreens Boots Alliance by 109.1% in the 2nd quarter. Bridgewater Associates LP now owns 657,649 shares of the pharmacy operator’s stock worth $39,469,000 after purchasing an additional 343,062 shares in the last quarter. Finally, Schaller Investment Group Inc. purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth $9,152,000. 64.29% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ WBA traded down $0.07 during mid-day trading on Friday, hitting $84.78. 111,098 shares of the company’s stock traded hands, compared to its average volume of 5,202,521. The company has a current ratio of 0.82, a quick ratio of 0.38 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $80.34 billion, a price-to-earnings ratio of 14.09, a P/E/G ratio of 1.32 and a beta of 0.74. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $85.13.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. On average, equities analysts predict that Walgreens Boots Alliance Inc will post 6.54 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.08%. The ex-dividend date of this dividend is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
In related news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the stock in a transaction dated Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total value of $4,096,040.00. Following the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kimberly R. Scardino sold 11,970 shares of the stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $79.79, for a total transaction of $955,086.30. The disclosure for this sale can be found here. Insiders have sold a total of 73,756 shares of company stock worth $5,824,194 over the last 90 days. Corporate insiders own 14.80% of the company’s stock.
Several analysts have commented on WBA shares. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research note on Tuesday, September 25th. BidaskClub cut shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 28th. Loop Capital boosted their price target on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, October 12th. Finally, Barclays boosted their price target on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Friday, October 12th. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $78.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: Return on Equity (ROE)
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.